| Recommended Mapping (based on statistical analysis) |
| Source ICD-9 | Mapping Type | Target ICD-10 |
| 99529 (Diagnosis) - Adv eff med/biol NEC/NOS (Unspecified adverse effect of other drug, medicinal and biological substance) with E9472 (Diagnosis) - Adv eff antidotes NEC (Antidotes and chelating agents, not elsewhere classified, causing adverse effects in therapeutic use) | Cluster To Single | T506X5A (Diagnosis) - Adverse effect of antidotes and chelating agents, init (Adverse effect of antidotes and chelating agents, initial encounter) |
| CMS/CDC General Equivalence Mappings |
| 99529 (Diagnosis) - Adv eff med/biol NEC/NOS (Unspecified adverse effect of other drug, medicinal and biological substance) with E9472 (Diagnosis) - Adv eff antidotes NEC (Antidotes and chelating agents, not elsewhere classified, causing adverse effects in therapeutic use) | Cluster To Single | Alternative #1: T506X5A (Diagnosis) - Adverse effect of antidotes and chelating agents, init (Adverse effect of antidotes and chelating agents, initial encounter) |
| Recommended Mapping (based on statistical analysis) |
| Source ICD-9 | Mapping Type | Target ICD-10 |
| 9095 (Diagnosis) - Lte efct advrs efct drug (Late effect of adverse effect of drug, medicinal or biological substance) with E9472 (Diagnosis) - Adv eff antidotes NEC (Antidotes and chelating agents, not elsewhere classified, causing adverse effects in therapeutic use) | Cluster To Single | T506X5S (Diagnosis) - Adverse effect of antidotes and chelating agents, sequela |
| CMS/CDC General Equivalence Mappings |
| 9095 (Diagnosis) - Lte efct advrs efct drug (Late effect of adverse effect of drug, medicinal or biological substance) with E9472 (Diagnosis) - Adv eff antidotes NEC (Antidotes and chelating agents, not elsewhere classified, causing adverse effects in therapeutic use) | Cluster To Single | Alternative #1: T506X5S (Diagnosis) - Adverse effect of antidotes and chelating agents, sequela |